Roche’s Tocilizumab Fails to Meet Endpoints in Phase 3 COVACTA Trial, However, Does Cut COVID-19 Death Rate in RECOVERY Trial
The use of an immunosuppressive therapy known as tocilizumab, approved to treat the indication of rheumatoid arthritis, has been tested […]